PharmaIndustry.ORG works on Research, Pharma
Marketing, Products, Clinical Trials, Financial, FDA, EMEA
discussions and Conferences.
Our mission is Collecting and Spreading the latest
Worldwide Pharmaceutical Industry News.
Fundamental Financial Accounting Concepts
Students are often overwhelmed by the amount of information presented in the introductory ...
$177.09
Bayer increases sales and earnings in the second quarter
Sales of the Bayer Group rose by 14.6 percent in the second quarter, to EUR 9,179 million (Q2 2009: ...
FDA Grants Priority Review to Cladribine Tablets
Merck KGaA announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the ...
Lilly Reports Strong Second-Quarter 2010 Results
Eli Lilly and Company (NYSE: LLY) announced financial results for the second quarter of 2010. In ...
Sanofi-aventis expresses concern over the approval of another version of enoxaparin sodium
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) has reservations on approval by the U.S. Food and Drug ...
Tracking down neuromuscular diseases
Neuromuscular diseases (NMDs) are chronic and so far incurable conditions that gradually affect ...
Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary
Former Idun Management team to expand efforts in liver disease and oncology SAN DIEGO, July 30 ...
Charles River Announces Mutual Termination of Acquisition Agreement with WuXi PharmaTech
– Board of Directors Approves $500 Million Stock Repurchase Plan – – Special Stockholder Meeting ...
Novartis Vaccines Launches Fluvirin Vaccine in US Market
From EquityBites (July 30, 2010) Healthcare solutions supplier Novartis Vaccines (NYSE:NVS) stated ...
Amgen's Second Quarter 2010 Adjusted Earnings Per Share Increased 7 Percent to $1.38
Second Quarter 2010 Revenue Increased 2 Percent to $3.8 Billion Second Quarter 2010 GAAP Earnings ...
Merck Announces Second-Quarter 2010 Financial Results
Second-Quarter 2010 Non-GAAP EPS of $0.86, Excluding Certain Items; Second-Quarter GAAP EPS of ...
FDA Advisory: Avoid Unintentional Exposure of Children and Pets to Evamist
ROCKVILLE, Md., July 29, 2010--The U.S. Food and Drug Administration is warning that inadvertent ...
FDA Advisory: Avoid Unintentional Exposure of Children and Pets to Evamist
ROCKVILLE, Md., July 29, 2010--The U.S. Food and Drug Administration is warning that inadvertent ...
Fashion Alert Medical Jewelry B-32 Multi Crystal Bracelet
fashionable alternative to standard medical id bracelets. strands beaded on elastic to ...
$18.1
Economy Continues To Impact Finances Of Health Companies
Despite a sluggish year, health care investors can look forward to growing emerging markets and a ...
Orexigen® Therapeutics Announces Publication Of COR-I Phase 3 Study Of Contrave In Lancet
Orexigen® Therapeutics, Inc. (Nasdaq: OREX) announced that results from its COR-I trial of ...
Latest Trial Against Wyeth Hormone Drug Starts In Philadelphia
The latest court case exploring the link between Wyeth Pharmaceuticals' hormonal replacement drug ...
Intra-Cellular Therapies Announces The Successful Completion Of A Phase Ib/II Study Of ITI-007 In Patients With Schizophrenia
Intra-Cellular Therapies, Inc. announced the results from a Phase Ib/II clinical trial in patients ...
ANA598 Demonstrates SVR12 In 100% Of First Group Of HCV Patients Randomized To Stop All Treatment At Week 24
Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced that six of six patients (100%) in the ANA598 ...
Source
: World Pharma News
& Medical News Today
